Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese investigators patent PAK4 inhibitors

March 7, 2022

FSH blockade improves cognition in preclinical models of AD

March 7, 2022

Genetic findings pave way to treatment of lymph disorder

March 7, 2022

ATH-1017 positively modulates HGF/MET axis and shows procognitive effects

March 4, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

Inhibiting DsbA inactivates resistance enzymes, sensitizing AMR bacteria to existing antibiotics

March 4, 2022

Biomind reports in vivo findings with DMT combination drug BMND-07

March 4, 2022

TRIM14 is a potential therapeutic target for treating inflammation-driven diseases

March 4, 2022

Engineered retinal cells stare daggers at peritoneal tumors

March 4, 2022

Phenanthroline derivative with antitumor activity in liver cancer models

March 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...